Stocks end higher overall, snapping a three-week losing streak

NEW YORK — Wall Street added to its recent gains on Friday with a broad rally that snapped the market’s three-week losing streak. Them&P 500 closed 1.5% higher, its third straight increase, and ended with a 3.7% gain for the week. That makes it the benchmark’s best week since July. Big gains for technology companies … Read more

COVID Boosters Targeting Omicron Expected This Week, But Experts Fear Low Uptake

The Food and Drug Administration is expected to authorize new COVID-19 booster shots this week that target the latest versions of the omicron variant, but will do so without data from a study showing the shots were safe and worked in humans. Authorizing doses, without data from human tests known as clinical trials, is similar … Read more

Study finds Pfizer’s antiviral has little to no benefit for young adults, and WHO says BA.5 omicron subvariant accounted for 74% of cases in past week

Pfizer’s COVID antiviral, Paxlovid, appears to have little to no benefit for young adults, although it still reduces the risk of hospitalization or death in older adults, according to a new Israeli study. Data from the study of 109,000 patients could renew questions about the US government’s use of Paxlovid, which has become the gold … Read more

Was the Fed’s Powell dovish or not? 4 key points from Wednesday’s press conference

Investors reacted as if Fed Chairman Jerome Powell’s Wednesday press conference was dovish, but many economists believe it was on the hawkish side of the street. Here are some of the key takeaways from Powell’s hour-long discussion with reporters about the state of the economy and central bank policy: Lily: Fed raises rates to tackle … Read more